Wei-Pang Chung

7PUBLICATIONS
82CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 06, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|May 26, 2026
Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

|Jan 30, 2026
Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An Evaluation.

Wei Kang, Chin-Yao Shen, Michael Chun-Yuan Cheng

|Dec 03, 2025
Premenopausal Patients With Clinically Aggressive Metastatic Breast Cancer Successfully Treated With a First-Line Palbociclib-Containing Regimen: Two Cases and Literature Review.

Pei-An Fu, Ya-Chun Hsu, Hui-Ping Hsu

|Jan 03, 2025
Circulating CD3+CD8+ T Lymphocytes as Indicators of Disease Status in Patients With Early Breast Cancer.

Han-Kun Chen, Yi-Ling Chen, Wei-Pang Chung

|Oct 01, 2024
Sacituzumab govitecan in HR+HER2- metastatic breast cancer: the randomized phase 3 EVER-132-002 trial.

Binghe Xu, Shusen Wang, Min Yan

Pageof 2

Frequent Collaborators

2 joint publications

Yen-Shen Lu

2 joint publications

Shin-Cheh Chen

1 joint publications

Binghe Xu

1 joint publications

Shusen Wang